View by type:
Documents (9878)
01e Annex C Proposed innovation approach for Gavi 5.0 pdf
1
Report to the Board
Board -2022 -Mtg -02 -Doc 01e -Annex C
Annex C: Proposed innovation approach for Gavi 5.0
This annex is a n extract of Section 2 of the May 2022 PPC paper
2.1 Innovation in Gavi 5.0 will be defined as new products, practices and
services that unlock more efficient and effective ways to accelerate
countries? immunisation objectives in line with Gavi?s mission. Rather
than a radical shift, the approach is an evolution of Gavi?s existing innovation
model a nd is intended to help accelerate progress towards reaching its
ambitious strategic goals for Gavi 5.0 and beyond 1.
2.2 A Theory of Change describes how the innovation approach will
contribute to Gavi ?s four strategic goals including access to COVID -19
vacci nes 2 (see Figure 1). The key expected outcomes of the innovation
approach are to accelerate the restoration of routine immunisation, reach more
zero -dose children, and help scale -up COVID -19 vaccination in an integrated
way. This will be achieved using new products, practices, and services across
priority programmatic areas at the country level. Gavi also expects innovations
to increase the effectivenes s, efficiency, and sustainability of immunisation
programmes. An example of an innovation that helped improve programmes?
effectiveness and efficiency is the eVIN 3 platform in India. eVIN was designed
to record supply chain transactions and collect data o n vaccine stock and
storage temperatures up to last -mile health facilities and led to significant
savings in vaccine utilisation (30%) and reduced stock -outs (by 40%) 4. Building
on eVIN and with Gavi support, the Government of India built a new tool, call ed
CoWIN integrating the tracking of COVID -19 vaccine beneficiaries. Applied to
routine immunisation, CoWIN could have a tremendous impact in reducing the
number of zero -dose and under -immunised children.
1 Innovations linked to Gavi?s operating model, policies, and processes are not part of this approach 2 At its December 2021 meeting the Board reconfirmed that ensuring access to COVID -19 vaccines are part of the recalibrated Gavi 5.0 priorities 3 Electroni c Vaccine Intelligence Network 4 eVIN 2018 Assessment report